Citizen United for Research in Epilepsy (CURE) Names New CEO

Chicago —Chicago-based nonprofit Citizens United for Research in Epilepsy (CURE) announced today that Carmita Vaughan has been selected as the organization’s new Chief Executive Officer effective November 1, 2010.

Prior to her new role at CURE, Vaughan served as Chief Strategy Officer of America’s Promise Alliance, a youth development organization founded by General Colin Powell and currently led by Alma J. Powell. Previously, as Chief of Staff of the Office of High Schools and High School Programs at Chicago Public Schools, Vaughan worked closely with Arne Duncan, U.S. Secretary of Education, to develop a comprehensive strategy to dramatically improve Chicago’s high school graduation rates.

“This is an amazing calling, as well as a critically important opportunity,” said Vaughan, whose mother suffered from epilepsy before her untimely death nine years ago. “I am extremely excited and humbled by the chance to lead this organization that seeks to find a cure for this disease and bring peace to the over three million Americans who suffer from epilepsy.”

"Carmita is the ideal person to lead CURE in this exciting new period of growth,” said Susan Axelrod, Chair of CURE. "We are determined to revolutionize research dynamics in epilepsy, and expand awareness and advocacy at all levels. Carmita’s diverse leadership experiences, along with her personal passion for this cause will facilitate a seamless transition. Her vision and leadership will set the stage for a strong future for CURE.”

Vaughan received a Master’s in Business Administration from Northwestern University’s Kellogg School of Management, and received her undergraduate degree in Chemical Engineering from the University of Michigan.

Read Carmita’s Story: http://www.cureepilepsy.org/psas/daughters_story.asp

CURE is a national nonprofit organization dedicated to finding a cure for epilepsy by raising funds for research and by increasing awareness of the prevalence and devastation of this disease. Since its inception in 1998, CURE has raised $15 million to fund epilepsy research and other initiatives that will lead the way to a cure. To date, CURE has awarded 100 cutting-edge research projects, sponsored many scientific workshops and conferences, and raised public awareness about epilepsy through television, print, radio, video productions and speaking opportunities.